Loading…
Story
regulates · 1
Quercetin's most interesting modern direction is clearing senescent cells (as a senolytic): damaged cells that did not finish dying get stuck in a state where they neither divide nor die, and keep releasing inflammatory factors that add to chronic inflammation throughout the body. Dasatinib plus quercetin (D+Q) is one of the few such approaches to reach human trials, and a preliminary trial in people with diabetic kidney disease saw fewer senescent cells; it remains an experimental treatment.